Will Zacks’ Value Upgrade Recast Credicorp’s (BAP) Role as a Diversified Financial Services Play?

Credicorp Ltd.

Credicorp Ltd.

BAP

0.00

  • In early May 2026, Zacks highlighted Credicorp as holding a Rank #2 (Buy) with a Value grade of A, pointing to attractive valuation metrics such as Forward P/E, P/B, and P/CF that suggest the stock may currently be undervalued.
  • An interesting angle for investors is how this recognition of Credicorp’s valuation and earnings outlook frames it as a potentially strong value-oriented financial services play, particularly given its diversified operations across banking, insurance, and health services.
  • We’ll now examine how Zacks’ favorable value rating and perceived undervaluation might influence Credicorp’s existing investment narrative and risk-reward profile.

AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Credicorp Investment Narrative Recap

To be a Credicorp shareholder, you need to believe in the strength of its diversified Peruvian-focused banking, insurance and health platform and its push into digital finance. Zacks’ recent Rank #2 (Buy) and Value grade of A highlight attractive valuation ratios, but this does not materially change the key near term story: the main catalyst remains execution in digital and fee-based growth, while concentrated exposure to Peru and regulatory uncertainty stay central risks.

Among recent announcements, the April 2026 decision to pay a PEN 50 per share annual dividend stands out in light of Zacks’ value call. For many investors, a sizeable cash return, following prior dividend increases, complements the argument that Credicorp’s earnings profile supports value credentials. At the same time, this capital return sits alongside ongoing investments in digital platforms and the higher cost-to-income ventures that are central to the medium term growth catalysts discussed earlier.

Yet alongside this, the company’s reliance on Peru and the ongoing PEN 1.6 billion tax dispute with SUNAT remain issues investors should be aware of...

Credicorp's narrative projects PEN31.3 billion revenue and PEN10.0 billion earnings by 2029. This requires 14.7% yearly revenue growth and about PEN3.1 billion earnings increase from PEN6.9 billion today.

Uncover how Credicorp's forecasts yield a $359.80 fair value, a 12% upside to its current price.

Exploring Other Perspectives

BAP 1-Year Stock Price Chart
BAP 1-Year Stock Price Chart

Some of the most optimistic analysts were already assuming earnings could reach about PEN 9.2 billion by 2028, which is far more upbeat than consensus and hinges on rapid digital monetization that may or may not be reinforced by Zacks’ recent value call.

Explore 5 other fair value estimates on Credicorp - why the stock might be worth as much as 34% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Credicorp research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Credicorp research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Credicorp's overall financial health at a glance.

Ready For A Different Approach?

Our top stock finds are flying under the radar-for now. Get in early:

  • Find 51 companies with promising cash flow potential yet trading below their fair value.
  • Uncover the next big thing with 25 elite penny stocks that balance risk and reward.
  • Capitalize on the AI infrastructure supercycle with our selection of the 40 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.